Related Experiment Video
Updated: Jul 23, 2025

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
Lanpeng Chen1, Eline Pronk1, Claire van Dijk1
1Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Inflammatory niche remodeling in acute myeloid leukemia (AML) represses normal hematopoietic stem cells (HSPCs) while sparing leukemia cells. This niche remodeling, however, offers a vulnerability for relapse-initiating cells during chemotherapy.
Area of Science:
- Hematology
- Oncology
- Stem Cell Biology
Background:
- Cancer initiation involves complex interactions between tumor cells and their microenvironment.
- Tumor-promoting inflammation is a key factor in tumorigenesis, but its precise mechanisms are not fully understood.
- Understanding intercellular signaling in the bone marrow niche is crucial for deciphering leukemia development.
Purpose of the Study:
- To decipher predicted intercellular signaling between hematopoietic stem/progenitor cells (HSPCs) and their neoplastic counterparts in the human bone marrow niche.
- To identify regulatory roles of stromal cells and the impact of inflammatory niche remodeling in NPM1-mutated acute myeloid leukemia (AML).
- To explore the association between stromal gene signatures, niche remodeling, and clinical outcomes in AML patients.
Main Methods:
- Adapted single-cell RNA sequencing was employed to predict intercellular signaling networks.
- Analysis focused on interactions within the native bone marrow niches of human AML patients.
- Stromal gene signatures were correlated with clinical data, including relapse rates and treatment outcomes.
Main Results:
- LEPR+ stromal cells were identified as central regulators of hematopoiesis through predicted interactions.
- Inflammatory niche remodeling was predicted to repress critical regulatory factors for HSPCs in AML, favoring clonal cell survival.
- Stromal gene signatures indicative of niche remodeling correlated with reduced relapse rates and favorable outcomes post-chemotherapy.
Conclusions:
- Inflammatory remodeling of stem cell niches drives tissue repression and clonal selection in human AML.
- This inflammatory process may create a vulnerability in relapse-initiating cells, exploitable by chemotherapeutic treatment.
- Deciphering intercellular communication in the AML niche provides insights into disease progression and therapeutic strategies.
More Related Videos
11:06Combining Intravital Fluorescent Microscopy IVFM with Genetic Models to Study Engraftment Dynamics of Hematopoietic Cells to Bone Marrow Niches
Published on: March 21, 2017
06:38Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line
Published on: August 2, 2021